552
Participants
Start Date
January 31, 2017
Primary Completion Date
August 5, 2022
Study Completion Date
August 5, 2022
Bedaquiline
Pretomanid
Moxifloxacin
Linezolid
Clofazimine
Locally accepted standard of care which is consistent with the WHO recommendations for the treatment of M/XDR-TB.
Helen Jospeh Hospital, Johannesburg
THINK Clinical Trial Unit, Hillcrest, Durban
King DinuZulu Hospital, Durban
Republican Scientific and Practical Centre for Pulmonology and Tuberculosis hospital, Minsk
Doris Goodwin Hospital, Pietermaritzburg
Republican TB Hospital No. 2, Nukus
Sh Alimov Republican Specialised Scientific-Practical Medical Centre for Phthysiology and Pulmonology Hospital, Tashkent
London School of Hygiene and Tropical Medicine
OTHER
Global Alliance for TB Drug Development
OTHER
University College, London
OTHER
Drugs for Neglected Diseases
OTHER
Swiss Tropical & Public Health Institute
OTHER
eResearch Technology, Inc.
INDUSTRY
Ministry of Health, Republic of Uzbekistan
OTHER_GOV
World Health Organization
OTHER
Ministry of Public Health, Republic of Belarus
OTHER_GOV
THINK TB & HIV Investigative Network
NETWORK
University of Liverpool
OTHER
Wits Health Consortium (Pty) Ltd
OTHER
Rutgers, The State University of New Jersey
OTHER
University of California, San Francisco
OTHER
Medecins Sans Frontieres, Netherlands
OTHER